CALSADA CRISPINA 4
4 · Regulus Therapeutics Inc. · Filed Jan 17, 2024
Insider Transaction Report
Form 4
CALSADA CRISPINA
Chief Financial Officer
Transactions
- Award
Common Stock
2024-01-12+11,250→ 11,250 total - Award
Stock Option (Right to Buy)
2024-01-12+85,000→ 85,000 totalExercise: $1.30Exp: 2034-01-11→ Common Stock (85,000 underlying)
Footnotes (2)
- [F1]On January 11, 2023, the reporting person was granted Restricted Stock Units (RSUs). The RSUs only vested upon achievement of a performance-based milestone. The performance criteria were met resulting in immediate vesting of 50% of the shares subject to the grant. The remaining 50% vest on the one year anniversary of the vesting commencement date, subject to the reporting person's Continuous Service to Regulus.
- [F2]The stock option will vest ratably on a monthly basis over a 48 month period subject to the reporting person's continuous service to Regulus through each such vesting date.